Timur Kulagin

Timur Kulagin

Auto-generated profile, based on publicly available information

Timur Kulagin

Biology and Biotechnology, National Research University Higher School of Economics, Moscow, Russia

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2025 in bioRxiv
Verified
Preprint
Open access
EKEvgeny Knyazev
Evgeny Knyazev
TKTimur Kulagin
Timur Kulagin
IAIvan Antipenko
Ivan Antipenko
ATAlexander Tonevitsky
Alexander Tonevitsky
Background: Preeclampsia (PE) complicates 2–8% of pregnancies and is marked by placental hypoxia and HIF-pathway activation, especially in early-onset PE (eoPE). Integrating patient tissue analyses with experimental models may reveal common molecular markers of trophoblast hypoxic response. Methods: We analyzed scRNA-seq data from 10 eoPE, 7 late-onset PE (loPE), and corresponding control placentas, identifying villous cytotrophoblast (VCT), syncytiotrophoblast (SCT), and extravillous trophoblast (EVT) subpopulations. BeWo b30 cells were treated for 24 h with CoCl 2 (300 µM) or an oxyquinoline derivative (OD, 5 µM) to induce hypoxia. RNA and small RNA sequencing quantified mRNA and microRNA changes. PROGENy inferred pathway activities. Results: Single-cell analysis revealed highest hypoxia pathway activation in eoPE, with EVT showing maximum activity among trophoblast populations. Nine genes were upregulated across all trophoblast types in eoPE: EBI3, CST6, FN1, RFK, COL17A1, LDHA, PKP2, RPS4Y1 , and RPS26. In vitro , OD induced more specific hypoxia responses than CoCl 2 , with 1,284 versus 3,032 differentially expressed genes respectively. Critically, EBI3, FN1 , and COL17A1 showed concordant upregulation in both placental tissue and OD-treated cells, while CoCl 2 treatment produced opposite expression patterns. MicroRNA analysis identified hsa-miR-27a-5p and hsa-miR-193b-5p as consistently elevated in both experimental conditions and previously reported in PE placental vesicles. We also identified isoforms of hsa-miR-9-5p and hsa-miR-92b-3p as hypoxia-associated in trophoblast. Conclusions: EBI3, COL17A1 , hsa-miR-27a-5p, and hsa-miR-193b-5p emerge as trophoblast hypoxia markers in PE. Oxyquinoline derivatives offer a more physiologically relevant in vitro hypoxia model than CoCl 2 . This integrated approach advances understanding of PE pathophysiology and suggests candidate therapeutic targets.

6 November 2026 in Current Medicinal Chemistry
Verified
Journal Article
Closed access
MSMariia Silkina
Mariia Silkina
MMMaria Mastykina
Maria Mastykina
TKTimur Kulagin
Timur Kulagin
MBMargarita Beskhizhko
Margarita Beskhizhko
ARAlexandra Razumovskaya
Alexandra Razumovskaya
SNSergey Nikulin
Sergey Nikulin
Three-dimensional prostate cancer organoids represent a promising platform for modeling tumor biology and personalizing therapeutic strategies. However, unlike many other solid tumors, reproducing this pathology in vitro is challenging. Despite initial culture establishment rates reaching 70-90% in certain studies, most cultures undergo early growth arrest (typically within passages P1-P3 or the first 1-2 months), accompanied by a high risk of losing the target tumor clone. In the present work, we provide a critical analysis of the current state of 3D prostate cancer culture technologies and attempt to identify the fundamental reasons for the inefficiency of standard multicomponent media and traditional extracellular matrices. Based on the analysis of single-cell transcriptomic profiling data, we characterized the adaptive drift of organoid cellular composition toward basal and transient states. Furthermore, we substantiated the critical need to modernize approaches for confirming model relevance, particularly by analyzing in detail the limitations of traditional markers. As an effective solution, we propose the concept of integrating multiplex expression test systems based on accessible quantitative PCR platforms, utilizing the extensive arsenal of highly informative RNA biomarkers accumulated in clinical urologic oncology. We conclude that the transition from empirical condition selection to directed niche reconstruction based on single-cell analysis data combined with PCR verification will open new opportunities for the widespread implementation of organoid models in basic research and clinical practice.